These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33085567)

  • 1. The LOCalizer Radiofrequency Identification System: An Effective New Technology for Localizing Non-Palpable Breast Lesions for Surgery.
    Cullinane CM; Byrne J; Akmenkalne L; O' Leary DP; Connors AM; Corrigan MA; Redmond HP; Kelly L; O' Sullivan MJ
    Surg Innov; 2021 Aug; 28(4):473-478. PubMed ID: 33085567
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiofrequency as a method of localizing impalpable breast lesions.
    Malik M; Brookes P; Kasana MI; Tromans L; Audrey Chew WY; Green MJ
    Surgeon; 2024 Oct; 22(5):296-300. PubMed ID: 39179450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter prospective cohort study to evaluate feasibility of radio-frequency identification surgical guidance for nonpalpable breast lesions: design and rationale of the RFID Localizer 1 Trial.
    den Dekker BM; Christenhusz A; van Dalen T; Jongen LM; van der Schaaf MC; Dassen AE; Pijnappel RM
    BMC Cancer; 2022 Mar; 22(1):305. PubMed ID: 35317766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of two non-radioactive alternatives to wire for the localization of non-palpable breast cancers.
    Lee MK; Sanaiha Y; Kusske AM; Thompson CK; Attai DJ; Baker JL; Fischer CP; DiNome ML
    Breast Cancer Res Treat; 2020 Jul; 182(2):299-303. PubMed ID: 32451679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microchipping the breast: an effective new technology for localizing non-palpable breast lesions for surgery.
    DiNome ML; Kusske AM; Attai DJ; Fischer CP; Hoyt AC
    Breast Cancer Res Treat; 2019 May; 175(1):165-170. PubMed ID: 30689105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of magnetic seed and RFID methods in the localization of non-palpable breast lesions.
    Sanli AN; Tekcan Sanli DE; Golshan M; Sezgin E; Celik V; Aydogan F
    J Cancer Res Ther; 2024 Jul; 20(5):1435-1439. PubMed ID: 39412908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire.
    Veyssiere H; Dressaire M; Pete R; Pinard C; Molnar I; Abrial C; Ginzac A; Durando X; Tekath M
    BMC Cancer; 2023 Jul; 23(1):679. PubMed ID: 37468859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency identification tag localization is comparable to wire localization for non-palpable breast lesions.
    McGugin C; Spivey T; Coopey S; Smith B; Kelly B; Gadd M; Hughes K; Dontchos B; Specht M
    Breast Cancer Res Treat; 2019 Oct; 177(3):735-739. PubMed ID: 31302856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radio-frequency identification (RFID) tag localisation of non-palpable breast lesions a single centre experience.
    Almalki H; Rankin AC; Juette A; Youssef MG
    Breast; 2023 Jun; 69():417-421. PubMed ID: 37141675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency localization of nonpalpable breast cancer in a multicentre prospective cohort study: feasibility, clinical acceptability, and safety.
    Christenhusz A; den Dekker BM; van Dalen T; Jongen L; van der Schaaf MC; Alic L; Ten Haken B; Pijnappel RM; Dassen AE
    Breast Cancer Res Treat; 2023 Aug; 201(1):67-75. PubMed ID: 37322358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Hologic LOCalizer radiofrequency identification (RFID) tags to localise impalpable breast lesions and axillary nodes: experience of the first 150 cases in a UK breast unit.
    Lowes S; Bell A; Milligan R; Amonkar S; Leaver A
    Clin Radiol; 2020 Dec; 75(12):942-949. PubMed ID: 32919756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective Review of Preoperative Radiofrequency Tag Localization of Breast Lesions in 848 Patients.
    Lamb LR; Gilman L; Specht M; D'Alessandro HA; Miles RC; Lehman CD
    AJR Am J Roentgenol; 2021 Sep; 217(3):605-612. PubMed ID: 33084384
    [No Abstract]   [Full Text] [Related]  

  • 13. Wireless Breast Localization Using Radio-frequency Identification Tags: The First Reported European Experience in Breast Cancer.
    Wazir U; Tayeh S; Perry N; Michell M; Malhotra A; Mokbel K
    In Vivo; 2020; 34(1):233-238. PubMed ID: 31882483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of shared learning of a new radiofrequency identification localization device-a UK iBRA-NET breast cancer localisation study.
    Morgan JL; Harvey J; Lowes S; Milligan R; Krizak S; Masannat Y; Carmichael A; Elgammal S; Youssef M; Petralia G; Dave RV;
    Clin Radiol; 2024 Nov; 79(11):e1288-e1295. PubMed ID: 39174422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First Reported Use of the Faxitron LOCalizer™ Radiofrequency Identification (RFID) System in Europe - A Feasibility Trial, Surgical Guide and Review for Non-palpable Breast Lesions.
    Malter W; Holtschmidt J; Thangarajah F; Mallmann P; Krug B; Warm M; Eichler C
    In Vivo; 2019; 33(5):1559-1564. PubMed ID: 31471405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective clinical study to evaluate the safety and performance of wireless localization of nonpalpable breast lesions using radiofrequency identification technology.
    Dauphine C; Reicher JJ; Reicher MA; Gondusky C; Khalkhali I; Kim M
    AJR Am J Roentgenol; 2015 Jun; 204(6):W720-3. PubMed ID: 26001262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of wire-guided localization (WGL) and radio-guided occult lesion localization (ROLL) in localization of non-palpable breast lesions.
    Elzohery YH; Gomaa MM; Mohamed G; Fadlalla WM; Taha SN; Ibraheem MH
    World J Surg Oncol; 2023 Aug; 21(1):266. PubMed ID: 37626332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium.
    van der Noordaa ME; Pengel KE; Groen E; van Werkhoven E; Rutgers EJ; Loo CE; Vogel W; Vrancken Peeters MJ
    Eur J Surg Oncol; 2015 Apr; 41(4):553-8. PubMed ID: 25707349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low re-excision rate for positive margins in patients treated with ultrasound-guided breast-conserving surgery.
    Yu CC; Chiang KC; Kuo WL; Shen SC; Lo YF; Chen SC
    Breast; 2013 Oct; 22(5):698-702. PubMed ID: 23333255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of wire-guided and radio-guided occult lesion localization for non-palpable breast lesions: A systematic literature review and meta-analysis of current evidence.
    Kiruparan N; Kiruparan P; Debnath D
    Asian J Surg; 2022 Jan; 45(1):79-88. PubMed ID: 34479779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.